NCT00179712View on ClinicalTrials.gov

Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

November 30, 2006

Conditions
Ovarian Cancer
Interventions
DRUG

CC-5013

DRUG

topotecan

Trial Locations (3)

43210

Ohio State University, Columbus

55455

University of MinnesotaObstetrics & Gynecology, MMC, Minneapolis

30912-3335

Medical College of GeorgiaDept of OBGYN, Augusta

Sponsors
All Listed Sponsors
collaborator

Prologue Research International

INDUSTRY

lead

Celgene Corporation

INDUSTRY

NCT00179712 - Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma | Biotech Hunter | Biotech Hunter